MRSA has very low affinity for β-lactam antibiotics, structurally speaking, what setup allows for the pathogen to have the said property?

My thought process in the question revolves around the mechanism of action for β-lactam antibiotics in combination with the structural (Genes, epitopes, etc.) make-up of the pathogen.

19 October 2020 3,283 10 View